(Q53920861)

22 May 2018

title

The effect of riluzole in amyotrophic lateral sclerosis: a study with cortical stimulation. (English)

1 reference

22 May 2018

amyotrophic lateral sclerosis

main subject

0 references

author

Anna Scalise

4

1 reference

22 May 2018

author name string

Desiato MT

1

1 reference

22 May 2018

Palmieri MG

2

1 reference

22 May 2018

Giacomini P

3

1 reference

22 May 2018

Arciprete F

5

1 reference

22 May 2018

Caramia MD

6

1 reference

22 May 2018

publication date

1 October 1999

1 reference

22 May 2018

Journal of the Neurological Sciences

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 May 2018

volume

169

1 reference

22 May 2018

issue

1-2

1 reference

22 May 2018

page(s)

98-107

1 reference

22 May 2018

Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

The pharmacology and mechanism of action of riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

An Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With Riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

'Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

The cortical silent period and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

The administration of guanidine in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Electric vs magnetic trans-cranial stimulation of the brain in healthy humans: a comparative study of central motor tracts 'conductivity' and 'excitability'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Brain excitability and electroencephalographic activation: non-invasive evaluation in healthy humans via transcranial magnetic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Corticocortical inhibition in human motor cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Distinguishing forms of generalized epilepsy using magnetic brain stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Motor inhibition and excitation are independent effects of magnetic cortical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Riluzole has no acute effect on motor unit parameters in ALS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Double cortical stimulation in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

Spinal motor neuron excitability during the silent period after cortical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900225-7

10.1016/S0022-510X(99)00225-7

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018